the future of cryoserger at your finger tips
CryoPen, Inc. Participates in Marketplace at the U.S. - Africa Leaders Summit
August 7, 2014
DALLAS, TX -- As part of the Investing In Our Future at the U.S. – Africa Leaders Summit hosted by First Lady Mrs. Michelle Obama and former First Lady Mrs. Laura Bush, Cryopen, Inc. participated in a Summit Marketplace on August 6, and presented the CryoPen® Cryosurgical System for Cervical Cancer Treatment to U.S. and African First Ladies and Summit guests. CryoPen, Inc. was part of a select group of companies and organizations chosen to participate in the Marketplace whose work is supporting women and girls in Africa.
Spring Conference on Correctional Health Care
April 20-23, 2013
DENVER, CO -- Cryopen will be set up in booth #508 at the Spring Conference on Correctional Health Care in Denver, CO on April 20-23, 2013. Come and learn about CryoPen's innovative GYN attachment for the treatment of genital warts, CIN 1, CIN 2, and skin lesions WITHOUT Liquid Nitrogen or Nitrous Oxide.
Medical Device Maker CryoPen, Inc. Selected to Present at WBT Innovative Marketplace in San Diego
SAN DIEGO--(BUSINESS WIRE)--CryoPen, Inc., developer and maker of the CryoPen® Cryosurgical System, announced today it has been selected to be a presenter at the tenth annual WBT Innovation Marketplace presented by Northrup Grumman taking place October 24 – 26, 2012 at the San Diego Convention Center.
CryoPen, Inc. Featured In Startech Foundation Annual Report
In the past, an effective cryosurgical tool that was simple and safe to use without cryogenic gases or liquids did not exist or was not accessible to all physicians. Because of their focus on research, development,and production, CryoPen has created a revolutionary cryosurgical system that is easy to use, accessible to more physicians, and gives accurate, consistent results not dependent on technical issues such as gas pressures, volumes or other difficult to control variables.
CryoPen Unveils Revolutionary New Cervical Cancer Treatment
GY2 Cryosurgical System Delivers Fast, Effective Treatment
August 15, 2012
Corpus Christi, Texas--(BUSINESS WIRE)--CryoPen, Inc., today announced that its new GY2 Cryosurgical System has been cleared by the Food and Drug Administration for use in gynecology. This new treatment will help medical professionals provide cervical cryosurgery without the traditional use of dangerous cryogenic gasses or liquids.
Texas Emerging Technology Fund Awards CryoPen, Inc. $2,000,000
Corpus Christi, Texas - CryoPen Inc. has been awarded a $2,000,000 technology development grant by the State of Texas Emerging Technology Fund (TETF) for the development and commercialization of the CryoPen Cryosurgical System®.
Great Things Are Happening
- CryoPen Participates in Marketplace at the U.S. - Africa Leaders Summit
April 7, 2014
- Spring Conference on Correctional Health Care
April 20-23, 2013
- Watch the actual freezing of a Planter Wart!